DUSA Pharmaceuticals, Inc. (DUSA) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $57.29 +1.18%
Financial Fact:
Product revenues: 9.74M
Today's EPS Names:
RCBC, GASS, YSG, More
Financial Fact:
Product revenues: 9.74M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA) reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $15.3 million versus the consensus estimate of $13.84 million.
For earnings history and earnings-related data on DUSA Pharmaceuticals, Inc. (DUSA) click here.
For earnings history and earnings-related data on DUSA Pharmaceuticals, Inc. (DUSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Chargepoint Holdings Inc. (CHPT) Tops Q2 EPS by 25c, Beats on Revenue
- Five Below raises full-year outlook after strong second-quarter sales growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
